GnRH antagonist cetrorelix inhibits mitochondria-dependent apoptosis triggered by chemotherapy in granulosa cells of rats

Gynecologic Oncology

Volumn 118, Issue 1, 2010, Pages 69-75

  Zhao, Xue jing ^a   Huang, Yan hong ^a   Yu, Yue cheng ^a   Xin, Xiao yan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cetrorelix; Chemotherapy; GnRH antagonist; Granulosa cell; Mitochondria

Indexed keywords

CASPASE 3; CETRORELIX; CYCLOPHOSPHAMIDE; CYTOCHROME C; ESTROGEN; HORMONE; PROGESTERONE; PROTEIN BAX; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOPLASM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ESTROGEN BLOOD LEVEL; FEMALE; FLUORESCENCE; GRANULOSA CELL; HORMONE BLOOD LEVEL; KINETICS; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NICK END LABELING; NONHUMAN; OUTCOME ASSESSMENT; OVARY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SECRETION; RAT; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CYCLOPHOSPHAMIDE; CYTOCHROMES C; CYTOPLASM; ESTRADIOL; FEMALE; GONADOTROPIN-RELEASING HORMONE; GRANULOSA CELLS; HORMONE ANTAGONISTS; IMMUNOHISTOCHEMISTRY; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; PROGESTERONE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77953290799     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.03.021     Document Type: Article

References (26)

1. Meirow D., and Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Updat 7 (2001) 535-543
2. Meirow D., Dor J., Kaufman B., Shrim A., Rabinovici J., Schiff E., et al. Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod 22 (2007) 1626-1633
3. Blumenfeld Z. How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embryo, oocytes, or ovaries. Oncologist 12 (2007) 1044-1054
4. Couzinet B., Lahlou N., Thomas G., Thalabard J.C., Bouchard P., Roger M., and Schaison G. Effects of gonadotrophin releasing hormone antagonist and agonist on the pulsatile release of gonadotrophins and alpha-subunit in postmenopausal women. Clin Endocrinol (Oxf) 34 (1991) 477-483
5. Weissman A., Ravhon A., Biran G., Levin D., Golan A., and Levran D. Follicular growth and development under continuous gonadotropin-releasing hormone antagonist administration. Fertil Steril 88 (2007) 1677
6. Blumenfeld Z., Avivi I., Eckman A., Epelbaum R., Rowe J.M., and Dann E.J. Gonadotropin releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma. Fertil Steril 89 (2008) 166-173
7. Meirow D., Assad G., Dor J., and Rabinovici J. The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice. Hum Reprod 19 (2004) 1294-1299
8. Morita Y., and Tilly J.L. Oocyte apoptosis: like sand through an hourglass. Dev Biol 213 (1999) 1-17
9. Loeffler M., and Kroemer G. The mitochondrion in cell death control: certainties and incognita. Exp Cell Res 256 1 (2000) 19--6
10. Finkel E. The mitochondrion: is it central to apoptosis?. Science 292 5517 (2001) 624-626
11. Brenner C., and Kroemer G. Apoptosis: mitochondria-the death signal integrators. Science 289 5482 (2000) 1150-1151
12. Amsterdam A., and Selvaraj N. Control of differentiation, transformation, and apoptosis in granulosa cells by oncogenes, oncoviruses, and tumor suppressor genes. Endocrinol Rev 18 (1997) 435-461
13. Markstrom E., Ech S., Shao R., et al. Surviao factors regulating ovarian apoptosis-dependence on follicle differentiation. Rdp Rodution 123 1 (2002) 23-30
14. Adrian C., and Martin S.J. The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. Trends Biochem Sci 26 (2001) 390-397
15. PeirÎ G., Diebold J., Baretton G.B., Kimmig R., and LÎhrs U. Cellular apoptosis susceptibility gene expression in endometrial carcinoma: correlation with Bcl-2, Bax, and caspase-3 expression and outcome. Int J Gynecol Pathol 20 (2001) 359-367
16. Reissmann T., Schally A.V., Bouchard P., Riethmiiller H., and Engel J. The LHRH antagonist cetrorelix: a review. Hum Reprod Update 6 (2000) 322-331
17. Yanhong H., and Xuejing Z. The GnRH antagonist reduces chemotherapy-induced ovarian damage in rats by suppressing the apoptosis. Gynecol Oncol 112 (2009) 409-414
18. Rabinovici J., and Jaffe R.B. Development and regulation of growth and differentiated function in human and subhuman primate fetal gonads. Endocr Rev 11 (1990) 532-557
19. Danforth D.R., Arbogast L.K., and Friedman C.I. Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists. Fertil Steril 83 (2005) 1333-1338
20. Earnshaw W.C. Nuclear changes in apoptosis. Curr Opin Cell Biol 7 (1995) 337-343
21. Check J.H., and Katsoff B. Ovulation induction and pregnancy in a woman with premature menopause following gonadotropin suppression with the gonadotropin releasing hormone antagonist, cetrorelix-a case report. Clin Exp Obstet Gynecol 35 (2008) 10-12
22. Zamzami N., and Kroemer G. The mitochondrion in apoptosis: how Pandora's box opens. Nat RevMol Cell Biol 2 1 (2001) 67-71
23. Jurisicova A., Atenos M., Varmuza S., et al. Expression of apoptosis related genes during human preimplantation embryo development: potential roles for the Harakiri gene product and caspase-3 in blastomere fragmentation. Mol Hum Repord 9 3 (2003) 133-141
24. Ishida H. The research method for investigating the role of the mitochondrial permeability transition pore in cell death. Nippon Yakurigaku Zasshi 123 5 (2004) 329-334
25. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 341 Pt 2 (1999) 233-249
26. Fan T.J., Han L.H., Cong R.S., et al. Caspase family proteases and apoptosis. Acta Biochim Biophys Sinica 37 11 (2005) 719-727